Pfizer has created a competitive grants award program to improve the care of patients with endocrine disorders as well as advance medical knowledge of the fundamental mechanisms of disease and potential future treatments.
The 2016 U.S. Aspire Endocrinology Award is designed to support exceptional investigators working in the field of endocrinology as well as advance the understanding of disease mechanisms or treatments through translational basic science or clinical research to enhance the clinical care of pediatric and adult patients with endocrine diseases.
The areas of research that this grant is focusing on are acromegaly in adults and growth hormone disorders in children. Any interested investigators in these fields should provide a research proposal that seeks to explore translational or clinical research in these areas.
Application is open to all U.S. investigators. Selection of the research proposals that are to be funded will be performed by an independent, external expert panel comprised of nationally known academic clinicians.
Available awards will be the following:
- One award of up to $100,000 over two years focusing on acromegaly in adults
- One award of up to $75,000 over two years focusing on growth hormone disorders in children
Funding is inclusive of indirect costs (capped at 28%).
The application process is currently open and concludes April 25, 2016.
Please go to www.aspireresearch.org for more information.
Loading ...